Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tissue Testing Technologies is developing ice-free cryopreservation solutions using vitrification and nanowarming technologies. Their work has demonstrated feasibility in small animal models with ongoing scale-up to porcine kidneys, followed by ex vivo human kidney testing. The company’s focus includes pediatric heart valve preservation, aiming to enable implants that grow with the patient—addressing a major unmet need in pediatric cardiac surgery. They have received multiple SBIR/STTR awards supporting these efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tissue Testing Technologies.